Oral delivery of peptides: opportunities and issues for translation

Affiliations

¹ UCD School of Veterinary Medicine and Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. Electronic address: david.brayden@ucd.ie.
² Dept. Of Pharmacy and Pharmaceutical Technology, CIMUS Research Institute, University of Santiago de Compostela, 15706 Campus Vida, Santiago de Compostela, Spain. Electronic address: mariaj.alonso@usc.es.

Editorial

David J Brayden et al. Adv Drug Deliv Rev. 2016.

. 2016 Nov 15;106(Pt B):193-195.

doi: 10.1016/j.addr.2016.10.005.

¹ UCD School of Veterinary Medicine and Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. Electronic address: david.brayden@ucd.ie.
² Dept. Of Pharmacy and Pharmaceutical Technology, CIMUS Research Institute, University of Santiago de Compostela, 15706 Campus Vida, Santiago de Compostela, Spain. Electronic address: mariaj.alonso@usc.es.

No abstract available

Keywords: anti-diabetic peptides; intestinal permeation enhancers; nanocarriers; nanomedicines; nanotoxicology; oral peptide delivery.

Comment on

Oral delivery of macromolecular drugs: Where we are after almost 100years of attempts.
Moroz E, Matoori S, Leroux JC. Moroz E, et al. Adv Drug Deliv Rev. 2016 Jun 1;101:108-121. doi: 10.1016/j.addr.2016.01.010. Epub 2016 Jan 27. Adv Drug Deliv Rev. 2016. PMID: 26826437 Review.